Similar articles

• [Current state of the treatment of arterial hypertension].

  Freis E. Freis E. Cardiology. 1980;66 Suppl 2:76-81. doi: 10.1159/000173011. Cardiology. 1980. PMID: 7026033 Clinical Trial. Spanish. No abstract available.
• Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.

  Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Ruilope LM, et al. Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006. Clin Ther. 2005. PMID: 15978306 Clinical Trial.
• Stroke in the elderly treated for systolic hypertension (SHEP).

  Singer RB. Singer RB. J Insur Med. 1991 Winter;23(4):265-9. J Insur Med. 1991. PMID: 10148513 No abstract available.
• Cardiovascular risks of hypertension: lessons from observational studies.

  O'Donnell CJ, Kannel WB. O'Donnell CJ, et al. J Hypertens Suppl. 1998 Oct;16(6):S3-7. J Hypertens Suppl. 1998. PMID: 9856377 Review.
• Are systolic/diastolic and isolated systolic hypertension risk factors for the elderly?

  Gifford RW Jr. Gifford RW Jr. Geriatrics. 1989 Oct;44 Suppl B:10-4. Geriatrics. 1989. PMID: 2680775 Review.